Publications by authors named "Kari A Shaver"
Front Immunol
October 2021
Article Synopsis
- Cancer immunotherapy enhances the body's immune system to fight tumors, but current approaches, like PD-1/PD-L1 blockade, often have low overall response rates, particularly in advanced cancers.
- Natural Killer (NK) cells are crucial for both the innate and adaptive immune responses, and their early activation can significantly improve the effectiveness of immunotherapies, despite many patients having compromised NK cell function.
- Adoptive allogeneic NK cell therapies show promise in boosting immunotherapy responses and are being explored in combination with other immune-oncology strategies to enhance treatment outcomes.
